Johnson & Johnson is suing the federal agencies overseeing the 340B program that makes discounted medicines more accessible to uninsured and underserved patients. J&J contends the Health Resources Services Administration can’t legally oppose its plan to implement a new rebate plan for certain 340B drugs.
The post Johnson & Johnson Takes the 340B Drug Rebate Fight to Federal Court appeared first on MedCity News.
